Successful Treatment of a Patient with Severe Churg-Strauss Syndrome by a Combination of Pulse Corticosteroids, Pulse Cyclophosphamide, and High-Dose Intravenous Immunoglobulin

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Asthma

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/02770900500263822PMID 16266953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Churg-Strauss Syndrome

  2004influential reference
• Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.

  2004cited by this paper
• Churg-Strauss syndrome.

  2003cited by this paper
• Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies

  2002cited by this paper
• Systematic reviews of treatment for inflammatory demyelinating neuropathy *

  2002cited by this paper
• Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)

  2002cited by this paper
• Churg-Strauss syndrome.

  2001cited by this paper
• Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

  2000cited by this paper
• Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins.

  1999cited by this paper
• Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin

  1999cited by this paper
• Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.

  1998cited by this paper
• Intravenous immunoglobulin as sole therapy for systemic vasculitis.

  1996cited by this paper
• Assessment of autonomic neurotoxicity in occupational and environmental health as determined by ECG R-R interval variability: a review.

  1996cited by this paper
• Gamma-globulin treatment of acute myocarditis in the pediatric population.

  1994cited by this paper
• Asthma and vasculitis. Response to intravenous immunoglobulins.

  1993cited by this paper
• Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.

  1991cited by this paper
• The treatment of Kawasaki syndrome with intravenous gamma globulin.

  1986cited by this paper
• The treatment of Kawasaki syndrome with intravenous gamma globulin.

  1986cited by this paper
• Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg‐Strauss Syndrome

  1984cited by this paper

• A case of eosinophilic granulomatosis with polyangiitis associated with diffuse alveolar haemorrhage: A case report and case-based review.

  2024cites this paper
• Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome).

  2013cites this paper
• An aggressive and lethal course of Churg–Strauss syndrome with alveolar hemorrhage, intestinal perforation, cardiac failure and peripheral neuropathy

  2012cites this paper
• The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade

  2012cites this paper
• Granulocyte death regulation by naturally occurring autoantibodies.

  2012cites this paper
• A severe form of Churg-Strauss syndrome complicated with acute cardiac failure and rapidly progressive peripheral neuropathy--a possible effect of intravenous immunoglobulin therapy.

  2011cites this paper
• Alveolar Hemorrhage in Vasculitis: Primary and Secondary

  2011cites this paper
• Interactive effects of corticosteroid and mechanical ventilation on diaphragm muscle function

  2011cites this paper
• Cell Death Modulation by Intravenous Immunoglobulin

  2010cites this paper
• Expression and Function of Siglec-8 in Human Eosinophils, Basophils, and Mast Cells

  2009cites this paper
• Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg).

  2008cites this paper
• Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies.

  2007cites this paper
• Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy.

  2007cites this paper
• The mechanisms, diagnosis, and management of severe asthma in adults.

  2006cites this paper